VITT with inactivated SARS-CoV-2 vaccine - index case

Kanta Devi; Natasha Ali; Nosheen Nasir; Syed Faisal Mahmood

doi:10.1080/21645515.2022.2036556

VITT with inactivated SARS-CoV-2 vaccine - index case

Hum Vaccin Immunother. 2022 Dec 31;18(1):2036556. doi: 10.1080/21645515.2022.2036556. Epub 2022 Mar 7.

Authors

Kanta Devi¹, Natasha Ali², Nosheen Nasir³, Syed Faisal Mahmood³

Affiliations

¹ Department of Oncology, Aga Khan University, Karachi, Pakistan.
² Department of Pathology & Laboratory Medicine/Oncology, Aga Khan University, Karachi, Pakistan.
³ Department of Medicine, Aga Khan University, Karachi, Pakistan.

Abstract

We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a 73-year-old gentleman who presented with pulmonary embolism and thrombocytopenia, two weeks after receiving inactivated COVID-19 vaccine. He responded well to nonheparin anticoagulation with complete resolution of symptoms and platelet count.

Keywords: COVID-19; VITT; inactivated vaccine.

Publication types

Case Reports

MeSH terms

Aged
COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
Male
Purpura, Thrombocytopenic, Idiopathic*
SARS-CoV-2
Thrombocytopenia* / chemically induced
Vaccines* / adverse effects

Substances

COVID-19 Vaccines
Vaccines

Grants and funding

The author(s) reported there is no funding associated with the work featured in this article.